 surgic chemotherapeut treatment hepat metastas carcinoma breast date year surviv rate patient hepat metastas HM breast origin chemotherapi hormon therapi studi surgic excis metastat diseas chemotherapi effect poor prognosi between may septemb patient diagnosi isol solitari multipl therapeut approach system preoper postop chemotherapi laparotomi find patient benign hepat lesion patient differ histolog type hepatectomi patient diffus metastat diseas attempt hepat resect patient hepatectomi possibl patient postop mortal minim morbid one-half patient metastas posit lymph node hepat pedicul median surviv time patient hepatectomi month hepatectomi month discoveri HM eleven patient metastas averag period month hepatectomi liver first site recurr patient underw hepatectomi patient free diseas month spite poor prognost featur excis specimen median surviv time time usual treatment procedur doubt benefit situat hepatectomi act cytoreduct surgic treatment main limit factor low effect chemotherapi type therapi restrict number patient studi protocol chemotherapi